27 results on '"Marin, David"'
Search Results
2. Younger haploidentical donor versus older matched unrelated donor for patients with AML / MDS
3. Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome
4. Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients
5. Significance of minimal residual disease monitoring by real‐time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes
6. Outcomes in patients with diabetes 10 years after liver transplantation
7. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning
8. Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation
9. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients
10. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation
11. PTCH1expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase
12. Excellent outcome after repeated changes of tyrosine kinase inhibitor therapy for chronic myeloid leukaemia in complete cytogenetic response due to minor side effects
13. A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia
14. Left Atrial Sphericity: A New Method to Assess Atrial Remodeling. Impact on the Outcome of Atrial Fibrillation Ablation
15. Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia
16. BCR-ABL1 kinase domain mutations: Methodology and clinical evaluation
17. Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system
18. Duplex quantitative PCR for molecular monitoring of BCR‐ABL1‐associated hematological malignancies
19. ChemInform Abstract: First Total Synthesis of (.+-.)-Helibisabonol A.
20. Technical aspects and clinical applications of measuringBCR-ABL1transcripts number in chronic myeloid leukemia
21. ChemInform Abstract: Rediscovering the Bioactivity and Ecological Role of 1,4‐Benzoxazinones
22. Does a rise in theBCR-ABL1transcript level identify chronic phase CML patients responding to imatinib who have a high risk of cytogenetic relapse?
23. Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis
24. Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remission
25. Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib
26. Clinical heterogeneity in chronic myeloid leukaemia reflecting biological diversity in normal persons
27. Natural Products as Allelochemicals. Part 14. Synthesis of Heliannane Skeletons. Facile Preparation of (.+-.)-Heliannuol D.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.